LSCRX
Price
$22.96
Change
+$0.07 (+0.31%)
Updated
Jul 10 closing price
Net Assets
353.41M
VSCIX
Price
$142.82
Change
-$0.29 (-0.20%)
Updated
Jul 10 closing price
Net Assets
188.57B
Interact to see
Advertisement

LSCRX vs VSCIX

LSCRX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
LSCRX vs. VSCIX commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSCRX is a Buy and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. LSCRX (353M). VSCIX pays higher dividends than LSCRX: VSCIX (1.20) vs LSCRX (0.75). LSCRX was incepted earlier than VSCIX: LSCRX (30 years) vs VSCIX (29 years). LSCRX (1.21) is less costly to investors than VSCIX (0.03). LSCRX is a more actively managed with annual turnover of: 36.00 vs. VSCIX (17.00). LSCRX has a lower initial minimum investment than VSCIX: LSCRX (2500) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.14 vs. LSCRX (5.91). VSCIX return over 5 years is better than : 34.89 vs. LSCRX (-26.03).
LSCRXVSCIXLSCRX / VSCIX
Total Expense Ratio1.150.033,833%
Annual Report Gross Expense Ratio1.210.034,033%
Fund Existence30 years29 years-
Gain YTD19.83315.758126%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets353M189B0%
Annual Yield % from dividends0.751.2063%
Returns for 1 year5.9122.1427%
Returns for 3 years-4.2748.92-9%
Returns for 5 years-26.0334.89-75%
Returns for 10 years-28.70158.01-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INMB1.940.15
+8.38%
INmune Bio
BROS67.561.92
+2.93%
Dutch Bros
GBLI26.110.01
+0.04%
Global Indemnity Group LLC
ACGLO18.95-0.13
-0.68%
Arch Capital Group Ltd
NVCR16.30-0.99
-5.73%
NovoCure Limited